IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Indegene IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1841.76 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Kotak Mahindra Capital Company , Nomura Financial Advisory And Securities (India) are the merchant bankers of Indegene IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 14th December 2022.
Indegene IPO posted revenues of ₹ 2626.33 crores and PAT of ₹ 322.53 crores in FY24 on annualised basis.
Revenue:
₹ 25.33 Cr.
EBITDA Margin:
21.05
% 
Net Worth: ₹ 13.00 Cr.
Market Capitalisation:
₹ 10814.07 Cr.
P/E:
33.53 times
P/BV: 5.83 times
EV/EBITDA: 2,776.20 times
Financial results of Indegene IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-23 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 25.00 | 22.00 | 13.00 | 5.00 | |
| Net Worth | 13.00 | 10.00 | 7.00 | 3.00 | |
| Total Debt | 3993.33 | 3943.36 | 182.38 | 247.55 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
19.00
25.33 |
23.00 | 16.00 | 9.00 | |
EBITDA
EBITDA on annualised basis |
4.00
5.33 |
4.00 | 2.00 | 2.00 | |
PAT
PAT on annualised basis |
2.00
2.67 |
2.00 | 1.00 | 1.00 | |
Indegene IPO PAT Margin is 10.53 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Indegene IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-23 | FY23 | FY22 | FY21 |
|---|---|---|---|---|
| EBITDA Margin (%) | 21.05 | 17.39 | 12.50 | 22.22 |
| PAT Margin (%) | 10.53 | 8.70 | 6.25 | 11.11 |
| EPS (₹) | 10.91 | 12.03 | 7.50 | 7.56 |
| ROE (%) | 15.38 | 20.00 | 14.29 | 33.33 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 8.00 | 9.09 | 7.69 | 20.00 |
| Debt to Equity | 307.18 | 394.34 | 26.05 | 82.52 |
The market Capitalisation of Indegene IPO is ₹ 10814.07 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Indegene IPO prospectus highlights an Return on Equity (ROE) of 15.38 % , Return on Assets (ROA) of 8.00 %, and an EBITDA Margin of 21.05 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Indegene IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Indegene IPO is ₹ 10814.07 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Indegene IPO has a Price-to-Earnings (PE) ratio of 33.53 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Indegene IPO reported revenue of ₹ 2626.33 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Indegene IPO provide insights into sales growth, market demand, and business scalability.
Indegene recorded an EBITDA of ₹ 5.33 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Indegene Profit After Tax (PAT) is ₹ 2.67 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 25.33 Cr.
EBITDA Margin:
21.05
%
Net Worth: ₹ 13.00 Cr.
Market Capitalisation:
₹ 10814.07 Cr.
P/E:
33.53 times
P/BV: 5.83 times
EV/EBITDA: 2,776.20 times
Indegene operates in Pharmaceutical and Digital-led Commercialization Services For The Life Sciences Industry. The Issue is listed on BSE,NSE in May, 2024. Indegene IPO size was 1841.76 with Issue price of 452.00 .
Merchant Banker(s) of Indegene IPO: Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited
Indegene IPO subscription was 70.30 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Indegene IPO listed at a listing price of 570.65 against the offer price of 452.00.
The current market price of Indegene is 574.65.
Why Us?
